Chemical Structure (Gabapentin 01)
Chemical structure of Gabapentin, showing a cyclohexane ring with an amino methyl and a carboxymethyl group attached.*
Gabapentin Tablet, Coated
Product Images NDC 82804-210
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
A line graph displaying mean pain scores over an 8-week period. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis measures mean pain score from 0 to 10. Two lines compare placebo and Gabapentin at 3,600 mg/day, showing a decrease in pain score over time with Gabapentin compared to relatively stable scores with placebo.*
Figure 2 (Gabapentin 03)
A line graph depicting mean pain scores over a 7-week period, comparing placebo with Gabapentin at doses of 1,800 mg/day and 2,400 mg/day. The graph indicates a 3-week dose titration period followed by a 4-week fixed dose period, showing pain score trends for each group from baseline through week 7.*
Figure 3 (Gabapentin 04)
A bar chart comparing the percentage outcomes of two studies with placebo (PBO) and gabapentin (GBP) at different doses. Study 1 shows 12% for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*
Figure 4 (Gabapentin 05)
A scatter plot chart presenting data from three studies labeled 'a', 'b', and 'c'. The x-axis shows daily dose in milligrams (600 to 1800 mg) and the y-axis shows difference percentage from 2 to 22%. Each study is represented by different markers: solid squares for study a, gray squares for study b, and white squares for study c, plotted at various dose levels with differing percentage values.*
82804-210-90 (Image 01)
Label of Gabapentin 600 mg coated tablets, with a package count of 90 tablets. The label shows the product is supplied by Proficient Rx LP and manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. The tablets are described as white, elliptical, film-coated, scored, and debossed with identifiers "OIE" and "600". Storage instructions and safety warnings are included.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
